Schedule 13D ownership disclosure
BRIACELL THERAPEUTICS ORD
Security class unavailable · CUSIP: 10778Y302
Event date: 2024-05-14
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 14.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-24-021272
- Form type
- SC 13D
- Filer
- BriaCell Therapeutics Corp.
- CIK
- CIK 1610820
- Filed
- May 24, 2024
- Reporting period
- May 14, 2024
- Description
- Schedule 13D beneficial ownership